Related references
Note: Only part of the references are listed.Transparency of COVID-19 vaccine trials: decisions without data
Sarah Tanveer et al.
BMJ EVIDENCE-BASED MEDICINE (2022)
Vaccines to prevent COVID-19: A living systematic review with Trial Sequential Analysis and network meta-analysis of randomized clinical trials
Steven Kwasi Korang et al.
PLOS ONE (2022)
SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
Stefan Pilz et al.
ENVIRONMENTAL RESEARCH (2022)
Update on SARS-CoV-2 seroprevalence: regional and worldwide
Ali Rostami et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19
Emma K. Accorsi et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2021)
Development and deployment of COVID-19 vaccines for those most vulnerable
Wayne C. Koff et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples
Eric Robinson et al.
VACCINE (2021)
The demography and characteristics of SARS-CoV-2 seropositive residents and staff of nursing homes for older adults in the Community of Madrid: the SeroSOS study
Francisco Javier Candel et al.
AGE AND AGEING (2021)
Theoretical Framework for Retrospective Studies of the Effectiveness of SARS-CoV-2 Vaccines
Joseph A. Lewnard et al.
EPIDEMIOLOGY (2021)
Reconciling estimates of global spread and infection fatality rates of COVID-19: An overview of systematic evaluations
John P. A. Ioannidis
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)
Worldwide Vaccination Willingness for COVID-19: A Systematic Review and Meta-Analysis
Kimberly R. Nehal et al.
VACCINES (2021)
Effectiveness of the WHO-Authorized COVID-19 Vaccines: A Rapid Review of Global Reports till 30 June 2021
Chang-Jie Cheng et al.
VACCINES (2021)
Protective Behaviors Against COVID-19 by Individual Vaccination Status in 12 Countries During the Pandemic
Rafael Goldszmidt et al.
JAMA NETWORK OPEN (2021)
COVID-19 vaccination and frailty in older adults
Liang-Kung Chen
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2021)
Over- and under-estimation of COVID-19 deaths
John P. A. Ioannidis
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2021)
Benefit of COVID-19 vaccination accounting for potential risk compensation
John P. A. Ioannidis
NPJ VACCINES (2021)
Predictors of Test Positivity, Mortality, and Seropositivity during the Early Coronavirus Disease Epidemic, Orange County, California, USA
Daniel M. Parker et al.
EMERGING INFECTIOUS DISEASES (2021)
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors
Antonio Vena et al.
JOURNAL OF CLINICAL MEDICINE (2020)
COVID-19 lockdown induces disease-mitigating structural changes in mobility networks
Frank Schlosser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Observational studies and the difficult quest for causality: lessons from vaccine effectiveness and impact studies
Marc Lipsitch et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2016)
The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials
G De Serres et al.
Eurosurveillance (2013)
Vaccine effects and impact of vaccination programmes in post-licensure studies
Germaine Hanquet et al.
VACCINE (2013)
The case test-negative design for studies of the effectiveness of influenza vaccine
Ivo M. Foppa et al.
VACCINE (2013)
The test-negative design for estimating influenza vaccine effectiveness
Michael L. Jackson et al.
VACCINE (2013)